Prediabetes

Clinical Trial Finder

Many patients with prediabetes are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Resistant Starch, Gut Bacteria and Diabetes

Conditions:   Diabetes Mellitus, Type 2;   Pre Diabetes
Intervention:   Dietary Supplement: SymbioIntest
Sponsors:   University of Hohenheim;   Institut für Mikroökologie GmbH
Recruiting - verified February 2017

Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study

Conditions:   Overactive Bladder;   Insulin Resistance
Intervention:  
Sponsor:   Duke University
Not yet recruiting - verified February 2017

Red Raspberry Polyphenols on Gut Microbiome

Conditions:   Healthy Subjects;   Pre-diabetes
Interventions:   Dietary Supplement: Raspberry and fructooligosaccharide;   Dietary Supplement: Raspberry
Sponsor:   Institute for Food Safety and Health, United States
Not yet recruiting - verified February 2017

Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies

Conditions:   Metabolic Syndrome;   Diabetes Mellitus, Type 2;   Pre Diabetes
Intervention:   Behavioral: Dietary Ketosis: Regulator of Obesity and Metabolic Syndrome
Sponsors:   Bristlecone Behavioral Health, Inc.;   University of Minnesota - Clinical and Translational Science Institute
Completed - verified February 2017

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and Metformin-treated Type 2 Diabetes

Condition:   Overweight and Obesity
Interventions:   Device: Gelesis200;   Device: Placebo
Sponsor:   Gelesis, Inc.
Not yet recruiting - verified February 2017

Evaluation of a Community Health Program for the Prevention of Type 2 Diabetes and Other Cardio-metabolic Risk Factors in Adults: Districts of Barranquilla and Bogota, Colombia - January 2017 - December 2019

Condition:   Prediabetic State
Interventions:   Behavioral: Intervention_ S;   Behavioral: Intervention_ I;   Behavioral: Intervention_ C
Sponsor:   Universidad del Norte
Not yet recruiting - verified February 2017

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Conditions:   Diabetes Mellitus, Type 2;   Impaired Glucose Tolerance (IGT);   Impaired Fasting Glucose (IFG)
Interventions:   Drug: Dapagliflozin;   Drug: Saxagliptin;   Drug: Pioglitazone;   Drug: Metformin
Sponsors:   The University of Texas Health Science Center at San Antonio;   American Diabetes Association;   AstraZeneca
Recruiting - verified February 2017

Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)

Conditions:   Rheumatoid Arthritis;   Insulin Resistance
Interventions:   Drug: Pioglitazone;   Drug: Placebo
Sponsor:   University of Alabama at Birmingham
Recruiting - verified February 2017

Effects of Artificial Sweeteners on Gut Microbiota and Glucose Metabolism

Condition:   Impaired Glucose Tolerance
Interventions:   Dietary Supplement: Sucralose-Aspartame;   Dietary Supplement: Aspartame-Sucralose
Sponsor:   University of Manitoba
Recruiting - verified July 2016

Phlebotomy and Polycystic Ovary Syndrome

Conditions:   Hyperandrogenism;   Metabolic Cardiovascular Syndrome
Interventions:   Procedure: Phlebotomy;   Drug: ethinylestradiol;   Drug: Cyproterone Acetate
Sponsors:   Manuel Luque Ramírez;   Instituto de Salud Carlos III
Recruiting - verified February 2017

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH

Condition:   Fatty Liver
Intervention:   Drug: Aramchol
Sponsors:   Galmed Pharmaceuticals Ltd;   Sharp Clinical Services;   Diamond Pharma Services;   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico;   ClinIntel;   Itamar-Medical, Israel;   One Way Liver OWL;   Medical University of Graz;   Tel-Aviv Sourasky Medical Center;   DSG EDC;   TransPerfect;   Clinical Reference Laboratory
Active, not recruiting - verified February 2017

Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Condition:   Obesity
Intervention:   Drug: Roflumilast
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 10, 2017

Effect of DPP4 Inhibition on Growth Hormone Secretion

Condition:   Obesity
Interventions:   Drug: Sitagliptin;   Drug: Pegvisomant;   Drug: Placebo;   Drug: L-NMMA;   Drug: Exendin 9-39
Sponsors:   Vanderbilt University;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified February 2017